Investors Research Corp Gsk PLC Transaction History

Investors Research Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$34.27 - $40.01 $13,708 - $16,004	-400 Reduced 2.44%	15,998 $571,000
Q4 2020 Jan 21, 2021	SELL	$34.07 - $39.94 $15,706 - $18,412	-461 Reduced 2.73%	16,398 $603,000
Q2 2020 Jul 21, 2020	SELL	$37.87 - $43.58 $8,520 - $9,805	-225 Reduced 1.32%	16,859 $688,000
Q1 2020 May 05, 2020	SELL	$32.47 - $48.83 $14,449 - $21,729	-445 Reduced 2.54%	17,084 $647,000
Q3 2019 Oct 22, 2019	SELL	$40.46 - $43.52 $8,092 - $8,704	-200 Reduced 1.13%	17,529 $748,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $4,213 - $4,525	-106 Reduced 0.59%	17,729 $712,000
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $11,407 - $12,314	288 Added 1.64%	17,835 $719,000
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $23,517 - $26,097	650 Added 3.85%	17,547 $686,000
Q4 2017 Feb 13, 2018	BUY	$35.34 - $41.9 $597,139 - $707,984	16,897	16,897 $599,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.